SCHEMBL3433367

SCHEMBL3433367

CCC(O)Cc1nc(Nc2cc(F)c(F)c(F)c2)nn1-c1cc(C)nc(C)c1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RAPGEF4 Q8WZA2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3770357 1.00 RAPGEF4 (0.30) RAPGEF4
SCHEMBL3781770 0.89 MAPK1 (0.33) —
SCHEMBL3434426 0.89 MAPK1 (0.33) —
SCHEMBL3776117 0.84 TP53 (0.31) —
SCHEMBL3431969 0.84 TP53 (0.31) —
SCHEMBL3776106 0.83 SRC (0.33) —
SCHEMBL3779354 0.81 SRC (0.33) —
SCHEMBL3768259 0.76 LMNA (0.30) —
SCHEMBL3428599 0.76 LMNA (0.30) —
SCHEMBL3781782 0.74 MAPK1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257535-A1 TRISUBSTITUTED 1, 2, 4 -TRIAZOIIES AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS Janssen Pharmaceutica N.V. (BE) 2010-12-08 — — EP disclosed
WO-2009115547-A1 TRISUBSTITUTED 1, 2, 4 -TRIAZOIIES AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2009-09-24 — — WO disclosed
Send feedback